Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesTopical overactive bladder gel found well-tolerated, effective
Urology Times, 06/30/09
Guttman C - Compared with patch systems, the gel formulation is free of enhancers or occlusion that can worsen skin-site reactions, and also avoids production of the primary oxybutynin metabolite through first-pass metabolism. This pharmacokinetic profile may explain why there is less dry mouth with the topical gel.
Related Articles
The importance of bladder wall thickness in the assessment of overactive bladder
Current Bladder Dysfunction Reports, 11/13/09
Relevance Score: 46%
192R Allele of Paraoxanase 1 (PON1) Gene as a New Marker for Susceptibility to Bladder Cancer
Anticancer Research, 11/10/09
Relevance Score: 46%
Significant Association of XPD Codon 312 Single Nucleotide Polymorphism with Bladder Cancer Susceptibility in Taiwan
Anticancer Research, 11/10/09
Relevance Score: 46%
Sequence Variant on 3q28 and Urinary Bladder Cancer Risk: Findings from the Los Angeles-Shanghai Bladder Case-Control Study
Cancer Epidemiology, Biomarkers & Prevention, 10/27/09
Relevance Score: 46%
Incidence analyses of bladder cancer in the Nile delta region of Egypt
Cancer Epidemiology, 10/20/09
Relevance Score: 46%
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder
Urology, 12/08/09
Total Cystectomy Versus Bladder Preservation Therapy for Locally Invasive Bladder Cancer: Effect of Combined Therapy Using Balloon-Occluded Arterial Infusion of Anticancer Agent and Hemodialysis With Concurrent Radiation
American Journal of Clinical Oncology, 12/08/09
Role and rationale of gene therapy and other novel therapies in the management of NMIBC
Expert Review of Anticancer Therapy, 12/08/09
Today in Voiding Dys/Incontinence...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder
Urology, 12/08/09
Minimally Invasive Therapy of Lower Urinary Tract Symptoms
Urologic Clinics of North America, 12/08/09
Age, gender, and voided volume dependency of peak urinary flow rate and uroflowmetry nomogram in the Indian population
Indian Journal of Urology, 12/08/09
Article Search
Sponsor